EV/EBITDA
-15.13
+0.11+0.72%
0 min ago
Summary
- As of February 7, 2025, TARS EV/EBITDA is -15.13, with a rise of +0.11 (+0.72%) during the most recent trading day.
- Over the past year, TARS EV/EBITDA has dropped by -8.89 (-142.47%).
- TARS EV/EBITDA is now -572.44% below its all-time high of -2.25.
Performance
TARS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TARS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.7% | -0.7% | -0.7% |
| 1 m1 month | +4.8% | -4.8% | -4.6% |
| 3 m3 months | -14.0% | +14.0% | +13.2% |
| 6 m6 months | -189.3% | +154.7% | +133.4% |
| ytdytd | +4.5% | -4.6% | -4.3% |
| 1 y1 year | -142.5% | +133.7% | +78.2% |
| 5 y5 years | - | - | - |
TARS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -18.9% | -16.49 | +8.3% | |
| 3 m | 3-month | -12.51 | -20.9% | -16.49 | +8.3% |
| 6 m | 6-month | -5.23 | -189.3% | -16.49 | +8.3% |
| 1 y | 1-year | -5.23 | -189.3% | -16.49 | +8.3% |
| 3 y | 3-year | -2.25 | -572.4% | -18.86 | +19.8% |
| 5 y | 5-year | -2.25 | -572.4% | -126.62 | +88.0% |
| alltime | all time | -2.25 | -572.4% | -126.62 | +88.0% |
Tarsus Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -15.13(-4.5%) |
| 2024 | -15.85(+319.3%) |
| 2023 | -3.78(-34.8%) |
| Date | Value |
|---|---|
| 2022 | -5.80(-75.5%) |
| 2021 | -23.65(-5.4%) |
| 2020 | -25.00 |
FAQ
- What is Tarsus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
- What is TARS EV/EBITDA year-to-date change?
- What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
What is Tarsus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of TARS is -15.13
What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high EV/EBITDA is -2.25
What is TARS EV/EBITDA year-to-date change?
Tarsus Pharmaceuticals EV/EBITDA has changed by +0.72 (+4.54%) since the beginning of the year
What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, TARS EV/EBITDA has changed by -8.89 (-142.47%)